首页> 外文期刊>American Journal of Dermatopathology >Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
【24h】

Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.

机译:淋巴瘤样丘疹病持续时间40年的继发性ALK阴性间变性大细胞淋巴瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

A 49 year-old man presented to our clinic. He had a history of lymphomatoid papulosis since childhood. At age 44, regional lymph node manifestation of anaplastic lymphoma kinase (ALK) anaplastic large cell lymphoma (ALCL) developed. Chemotherapy resulted in complete remission of the lymphadenopathy. Four years later, systemic relapse was detected which was refractory to therapy. Histology and immunohistochemistry showed congruent characteristics of multiple skin and lymph node biopsies: diffuse mixed infiltrate with large, anaplastic CD30 cells. Immunophenotype and microscopic morphology suggested a common origin of the different manifestations-however, this could not be proven due to lack of T-cell receptor (TCR) gamma gene rearrangement in most of the samples. The diagnosis of ALK-negative systemic ALCL with cutaneous symptoms was set up at the second flare up, however, the possibility of primary cutaneous ALCL was not excluded steadily. Lymphomatoid papulosis, primary cutaneous ALCL, and systemic ALK ALCL are 3 different entities but the separation of them cannot be solved without distinctive diagnostic tools.
机译:一名49岁的男子到我们诊所就诊。他从小就有淋巴瘤性丘疹病史。在44岁时,出现了间变性淋巴瘤激酶(ALK)间变性大细胞淋巴瘤(ALCL)的区域淋巴结表现。化学疗法可完全缓解淋巴结病。四年后,发现全身复发,治疗难以治愈。组织学和免疫组化显示了多个皮肤和淋巴结活检的一致特征:弥漫性混合浸润,带有变性的大CD30细胞。免疫表型和显微镜形态学提示了不同表现形式的共同起源,但是由于大多数样本中缺乏T细胞受体(TCR)γ基因重排,因此无法证明这一点。在第二次发作时诊断为具有皮肤症状的ALK阴性全身性ALCL,但是,未稳定排除原发性皮肤ALCL的可能性。淋巴瘤样丘疹病,原发性皮肤ALCL和全身性ALK ALCL是3个不同的实体,但是如果没有独特的诊断工具就无法解决它们的分离。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号